Sofosbuvir-13C-d3 CAS 2070009-25-3
| CAS No. | 2070009-25-3 |
| Molecular Formula | C21[13C]H28D3FN3O9P |
| Molecular Weight | 535.48 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 535.48 g/mol gives Sofosbuvir-13C-d3 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
CATO supplies Sofosbuvir-13C-d3 (CAS 2070009-25-3), a certified reference material (molecular formula C21[13C]H28D3FN3O9P, MW 535.48 g/mol) for analytical method development and quality control.
Based on its molecular formula C21[13C]H28D3FN3O9P, Sofosbuvir-13C-d3 contains deuterium isotope labeling, a flavonoid core, an amide group, a phosphate ester group, a hydroxyl group, an ether linkage, fluorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 535.48 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Sofosbuvir-13C-d3 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C21[13C]H28D3FN3O9P |
| Molecular Weight | 535.48 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1997 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Sofosbuvir Standards
- Sofosbuvir D6 (CAS 1868135-06-1)
- Sofosbuvir (CAS 1190307-88-0)
- Sofosbuvir Impurity 22 (CAS 1190308-01-0)
- Sofosbuvir Impurity 23 (CAS CATO-C4X-105223)
- Sofosbuvir Impurity 24 (CAS CATO-C4X-105224)
- Sofosbuvir Impurity 25 (CAS CATO-C4X-105225)
- Sofosbuvir Impurity 26 (CAS CATO-C4X-105226)
- Sofosbuvir Impurity 27 (CAS CATO-C4X-105227)
Recommended Standards
- tert-butyl (3R,5R,6S)-2-oxo-5,6-diphenyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl]morpholine-4-carboxylate (CAS 1345672-85-6)
- Lusutrombopag Impurity 32 (CAS CATO-C4X-208432)
- Mometasone Furoate EP Impurity J (CAS CATO-C4X-17049)
- GNF 5837 (CAS 1033769-28-6)
- (2E)-3-(3-Bromophenyl)-1-(4-fluorophenyl)prop-2-en-1-one (CAS 1638607-61-0)
- (E)-[(4-Chlorophenyl)methylidene]amino 4-tert-butylbenzoate (CAS 331462-08-9)
- 2-Methyl-1,3-dioxolane-2-propanoic Acid (CAS 4388-57-2)
- 7-Chloro-6-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one (CAS 1185320-25-5)
- Tiotropium Impurity 26 (CAS 10299-90-8)
- Ethyl (s)-3-amino-3-(furan-2-yl)propanoate (CAS 1027996-73-1)
- 2-Propoxypropanoic acid (CAS 56674-67-0)
- (1R)-1-(4-tert-butylphenyl)ethan-1-amine (CAS 511256-38-5)
- Tert-butyl 3,3-difluorohexahydropyrrolo[3,2-b]pyrrole-1(2H)-carboxylate (CAS 1251020-22-0)
- Neuropeptide W-23 (human) (CAS 383415-79-0)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com